Enlibio Biotech is located in Wuhan Optics Valley BioCity. We are mainly engaged in the R&D, production and sales of various research proteins, antibodies, ELISA kits and related products, and provide technical services, training and consulting
19A; CS1; CD319; CRACC; protein 19A; CD2 subset 19A24 protein; SLAM family member membrane protein FOAP-12; CD2-like receptor activating cytotoxic cells; novel LY9 (lymphocyte antigen 9) like protein
KALI; NTBA; CD352; KALIb; Ly108; NTB-SF2000; NTBA receptor; NK-T-B-antigen; SLAM family member activating NK receptor; natural killer-, T- and B-cell antigen